Skip to main content

Creative Planning

Position in CLDX — Celldex Therapeutics, Inc.

CIK 1540235 OVERLAND PARK, KS

Position in CLDX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,327,280
+$266,691 QoQ
Shares Held
35,670
+6.7% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#111
of 252 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 2% Shared 0% None 98%

Common Shares in CLDX Over Time

Shares Held

Position Value (USD)

Derivatives in CLDX

reported options exposure · as of Jun 30, 2023
CallValue
$0
CallShares
0
PutValue
$4,725
PutShares
9,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. CLDX ranks #69 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLDX

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,327,280 35,670
2026-03-31 $1,060,589 33,436
2025-12-31 $852,932 31,404
2025-09-30 $860,694 33,270
2025-06-30 $608,505 29,902
2025-03-31 $429,592 23,669
2024-12-31 $501,710 19,854
2024-09-30 $503,697 14,819
2024-03-31 $207,499 4,944
2023-12-31 $920,310 23,205
2023-09-30 $573,021 20,822
2023-06-30 $687,828 20,272
2023-06-30 $4,725 9,000
2023-03-31 $728,918 20,259
2023-03-31 $14,556 9,000
2022-12-31 $1,504 19,600
2022-12-31 $897,996 20,148
2022-09-30 $49,000 19,600
2022-09-30 $556,718 19,805
2022-06-30 $532,513 19,752
2022-03-31 $30,000 19,600
2022-03-31 $671,254 19,708
2021-12-31 $761,517 19,708
2021-09-30 $1,301,590 24,108
2021-06-30 $806,171 24,108
2021-03-31 $497,428 24,147
2020-12-31 $615,775 35,147
2020-09-30 $524,196 35,347
2020-06-30 $459,511 35,347
2020-03-31 $20,164 12,147